ISTI LOGO
Towards a new dawn
×

img Acces sibility Controls

Technologies Banner

Research Projects

BBV154 - A novel adenovirus vectored, intranasal vaccine for COVID-19

Implementing Organization

Bharat Biotech Pvt. Ltd., Hyderabad

About

DBT-BIRAC supported India's first Intranasal vaccine to prevent COVID-19 by Bharat Biotech private limited

Outcome / Output

Immune responses at the site of infection (in the nasal mucosa) – essential for blocking both infection and transmission of COVID-19. The technology helps for pandemic preparedness

Source

Source URL
technologies/bbv154-novel-adenovirus-vectored-intranasal-vaccine-covid-19

Related Research

View All
  • No related research found.
Quick Information
Focus Area
Vaccines, Infectious Diseases
Status
completed
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
00
No. of Patents
Filed : 00
Grant : 00
Disclaimer: Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
arrowtop
Latest Updates
Loading…
Recently added across the portal